WEST LAFAYETTE, Ind., April 2, 2014 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT) announced today the closing of its previously announced underwritten public offering of 5,175,000 shares of its common stock at a price to the public of $21.00 per share, which includes the exercise in full by the underwriters of their option to purchase 675,000 additional shares. Endocyte received net proceeds of approximately $101.8 million from the offering after deducting underwriting discounts and commissions and estimated expenses relating to the offering.
Help employers find you! Check out all the jobs and post your resume.
